[M–COOC2H5]+, 132 (12) [M–CO2–C2H4–CH3CN]+, 131 (39) [M–CH3CN–COOC2H5]+, 103 (51), 92 (17)
[C6H5CH3], 91 (100) [C6H5N], 77 (42.8) [C6H5], 64 (26). Found, %: C 63.51; H 6.41; N 17.31. C13H15N3O2.
Calculated, %: C 63.66; H 6.16; N 17.13.
Interaction of 2-Ethoxycarbonyl-1,4,6-trimethylpyrimidinium Iodide (1a) with p-Hydrazino-
benzoic Acid. A mixture of iodide 1a (1 g, 3 mmol) and p-hydrazinobenzoic acid (0.91 g, 6 mmol) in absolute
ethanol (15 ml) was heated in a sealed ampule on a water bath for 15 h. The alcohol was distilled off and the
residue was treated with hot benzene. The crystals precipitated from the benzene solution on cooling were
filtered off, washed with hexane, and dried. 1-(p-Carboxyphenyl)-3-(ethoxycarbonyl)methyl-5-methyl-
1,2,4-triazole (4b) (0.25 g, 29%) was obtained of mp 196-197°C, Rf 0.51 (benzene–acetone, 2:1). The residue
from the benzene solution was separated preparatively in benzene–acetone, 8:1, and 3-ethoxycarbonyl-
4,6-dimethylpyrid-2-one (3) (0.2 g, 36%) and 2-ethoxycarbonylmethyl-4,6-dimethylpyrimidine (0.2 g, 34%),
1
identical with known specimens, were isolated. H NMR spectrum of compound 4b (DMSO–d6–CCl4, 1:3), δ,
ppm (J, Hz): 1.25 (3H, t, J = 7.1, CH3); 2.54 (3H, s, CH3); 3.70 (2H, s, CH2); 4.14 (2H, q, J = 7.1, OCH2); 7.70
(2H, d, J = 8.6, H-3,5Ar); 8.10 (2H, d, J = 8.6, H-2,6Ar); 13.0 (1H, br. s, COOH). 13C NMR spectrum of
compound 4b, δ, ppm: 13.0 (CH3); 13.8 (CH3); 33.8 (CH2); 60.1 (OCH2); 123.1 and 130.3 (2,3,5,6-CAr); 130.5
(4-CAr); 140.2 1-CAr); 152.3 (C=N); 156.8 (C=N); 166.1 (CO); 168.1 (CO). Found, %: C 57.80; H 5.01; N 14.31.
C14H15N3O4. Calculated, %: C 58.13; H 5.23; N 14.53.
Interaction of 2-Ethoxycarbonyl-1,4,6-trimethylpyrimidinium Iodide (1a) with 2-Benzyl-
4-hydrazino-6-methylpyrimidine. A mixture of iodide 1a (0.34 g, 1 mmol) and 2-benzyl-4-hydrazino-
6-methylpyrimidine (0.42 g, 2 mmol) in absolute ethanol (7 ml) was heated in a sealed ampule on a water bath
for 20 h. The alcohol was distilled, the residue was washed sequentially with hexane, benzene, and acetone, all
being hot. From the benzene solution 1-(2-benzyl-4-methyl-6-pyrimidinyl)-3-(ethoxycarbonyl)methyl-5-methyl-
1,2,4-triazole (4c) (150 mg, 43%) was obtained with mp 85-86oC, Rf 0.72 (benzene–acetone, 5:1). The crystals
precipitated on cooling the acetone solution were filtered off and the hydroiodide of the initial hydrazino-
pyrimidine (150 mg) was obtained having mp 275-277°C. From the hexane solution the ethyl ester of
1
4,6-dimethyl-2-methylaminonicotinic acid (20 mg, 10%) was obtained and corresponded in TLC and H NMR
1
spectrum with a authentic sample. H NMR spectrum of compound 4c (DMSO-d6–CCl4, 1:3), δ, ppm (J, Hz):
1.28 (3H, t, J = 7.1, CH3); 2.56 (3H, s, CH3); 3.63 (2H, s, CH2); 4.14 (2H, q, J = 7.1, OCH2); 4.18 (2H, s,
CH2C6H5); 7.14-7.32 (5H, m, C6H5); 7.56 (1H, s, H-5Pyr). Mass spectrum (EI), m/z, (Irel, %): 352 (24.9) [M+H]+,
351 (100) [M]+, 350 (23.2) [M–H]+, 278 (16.7) [M–COOC2H5]+, 277 (14.8) [M–H–COOC2H5]+, 238 (17.2) [M–
CO2–C2H4–CH3CN]+, 237 (25.5) [M–COOC2H5–CH3CN]+, 197 (35.1) [M–CO2–C2H4–CH3CN–CH3CN]+, 91
(38.7) [C7H7]. Found, %: C 65.21; H 5.80; N 19.59. C19H21N5O2. Calculated, %: C 64.94; H 6.02; N 19.93.
Interaction of 2-Carbamoylmethyl-1,4,6-trimethylpyrimidinium Iodide (1b) with 2-Benzyl-
4-hydrazino-6-methylpyrimidine. A mixture of iodide 1b (0.31 g, 1 mmol) and 2-benzyl-4-hydrazino-
6-methylpyrimidine (0.42 g, 2 mmol) in absolute ethanol (7 ml) was heated in a sealed ampule on a water bath
for 25 h. The solid was filtered off. On cooling the alcohol solution 1-(2-benzyl-4-methyl-6-pyrimidinyl)-
3-carbamoylmethyl-5-methyl-1,2,4-triazole (4d) (0.1 g, 31%) was precipitated, mp 171-172oC, Rf 0.44 (acetone).
2-Carbamoylmethyl-4,6-dimethylpyrimidine (0.1 g, 55%), identical by TLC with an authentic sample, was
1
isolated from the filtrate by a preparative separation on a column of silica gel. H NMR spectrum of compound
4d (CDCl3), δ, ppm: 2.60 (3H, s, CH3); 2.70 (3H, s, CH3); 3.72 (2H, s, CH2); 4.28 (2H, s, CH2C6H5); 5.65 (1H, br. s,
NH2); 6.95 (1H, br. s, NH2); 7.22-7.37 (5H, m, C6H5); 7.56 (1H, s, H-5Pyr). 13C NMR spectrum of compound 4d, δ,
ppm: 16.6 (CH3); 23.5 (CH3); 35.7 (CH2); 44.5 (CH2C6H5); 108.2 (5-CPyr); 127.3 (p-C6H5); 128.9 and 129.8 (o- and
m-C6H5); 136.8 (ipso-C); 156.8, 157.8, 158.6, 169.0, 169.1, and 169.4 (C=N and C=O). Mass spectrum (EI), m/z (Irel,
%): 323 (23) [M+H]+, 322 (95) [M]+, 321 (13.5) [M–H]+, 280 (22) [M–H–CH3CN]+, 279 (100) [M–H–CONH2]+,
278 (14) [M–CONH2]+, 238 (19) [M–HNCO–CH3CN]+, 237 (15) [M–CONH2–CH3CN]+, 197 (21) [M–HNCO–
CH3CN–CH3CN]+, 184 (14), 91 (67) [C7H7]. Found, %: C 63.61; H 5.38; N 25.78. C17H18N6O. Calculated,
%: C 63.34; H 5.63; N 26.07.
999